Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

scientific article

Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00415-010-5823-X
P698PubMed publication ID21088848
P5875ResearchGate publication ID47815967

P50authorCorrado AngeliniQ37379259
Giovanna CenacchiQ60057884
P2093author name stringElena Pegoraro
Marina Fanin
Valentina Papa
P2860cites workAuto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodiesQ28202947
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivoQ28280767
Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of AmericaQ33909223
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targetsQ35172323
Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravisQ35487694
The features of myasthenia gravis with autoantibodies to MuSK.Q35489482
Clinical evaluation and management of myasthenia gravisQ35723879
Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disordersQ36003423
Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravisQ36254764
Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?Q36858180
alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clusteringQ37052262
Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neuronsQ37165781
Autoimmune disorders of the neuromuscular junctionQ37313844
Myasthenia and related disorders of the neuromuscular junctionQ37765073
Update on muscle-specific tyrosine kinase antibody positive myasthenia gravisQ37770903
MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivoQ40364092
Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses.Q41859552
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entityQ41903804
Pre- and postsynaptic neuromuscular junction abnormalities in musk myastheniaQ43026148
Clinical aspects of MuSK antibody positive seronegative MG.Q44488131
"Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinaseQ44813150
Are MuSK antibodies the primary cause of myasthenic symptoms?Q44927340
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravisQ45237165
Seronegative myasthenia gravis: disease severity and prognosisQ46482934
Anti-MuSK myasthenia gravis presenting with purely ocular findingsQ46547044
MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patternsQ47757821
Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravisQ48268784
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravisQ48556624
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.Q50773236
MuSK signaling at the neuromuscular junction.Q51998372
Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.Q54769260
Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscleQ60532160
Myasthenia gravisQ72436386
Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravisQ79325631
Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell culturesQ79868039
P433issue5
P921main subjectmyasthenia gravisQ8285
antibodyQ79460
P304page(s)746-752
P577publication date2010-11-19
P1433published inJournal of NeurologyQ6295649
P1476titleComparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies
P478volume258